| Drug
Metabolism Letters
ISSN: 1872-3128 - Volume 2, 4 Issues, 2008

Editor-in-Chief:
Chandra Prakash
Global Research and Development
Pfizer, Inc., Groton, CT
USA
Associate Editors for USA:
Urs A. Boelsterli (University
of Connecticut, Storrs, CT, USA)
Judy Bolton (The University of Illinois, Chicago,
IL, USA)
Michael Murray (University of Sydney, Sydney,
Australia)
Associate Editors
for Asia:
S. Zhou (RMIT University, Bundoora, Victoria,
Australia)
Lee Jia (National Cancer Institute/NIH ,
Rockville, MD, USA)
Ken-ichi Fujita (Saitama Medical University,
Saitama, Japan)
Associate
Editor for Europe:
H.K. Kroemer (Ernst Moritz Arndt
University Greifswald, Greifswald, Germany)
Nico P.E. Vermeulen (Vrije Universiteit Amsterdam,
Amsterdam, The Netherlands)
Associate
Editor for Australia:
Ross McKinnon (University of South Australia,
Adelaide, Australia)
Michael Murray (University of Sydney, NSW
2006, Australia)
Editorial
Advisory Board:
B. Ackermann (Eli Lilly and
Company, Greenfield, IN, USA)
T.B. Andersson (AstraZeneca R&D, Mölndal,
Sweden)
K. Bachmann (The University of Toledo, Toledo,
OH, USA)
G. Baker (University of Alberta, Edmonton,
Alberta, Canada)
S.K. Balani (Millennium Pharmaceuticals Inc.
Cambridge, MA, USA)
M. Balazy (New York Medical College, Valhalla,
NY, USA)
K. Beaumont (Pfizer Global Research and Development,
Sandwich Kent, UK)
G.D. Bowers (GlaxoSmithKline, Research Triangle
Park, NC, USA)
J. Caldwell (University of Liverpool, Liverpool,
UK)
D. Capone (Federico II University,Naples,
Italy)
S. Chong (Bristol-Myers Squibb R&D, Pennington,
NJ, USA)
R. Dickinson (University of Queensland at
Royal Brisbane Hosp., Queensland, Australia)
S. Ekins (University of Maryland, Baltimore,
MA, USA)
R. Franklin (Array Biopharma Inc., Boulder,
CO, USA)
E.M.J. Gillam (The University of Queensland,
St. Lucia, Australia)
Hansruedi Glatt (German Institute of Human
Nutrition (DIfE), Nuthetal, Germany)
M.J. Gómez-Lechón (La Fe Hospital,
Valencia, Spain)
W.G. Humphreys (Bristol-Myers Squibb, Princeton,
NJ, USA)
T. Hussain (University of Houston, Houston,
TX, USA)
M. Kajbaf (GlaxoSmithKline S.p.A., Fleming,
Verona, Italy)
E. Kantharaj (PKDM and Preclinical Development
S*BIO Pte Ltd., Singapore)
K Kassahun (Drug Metabolism Merck & Co,
West Point, PA, USA)
T. Kawase (Institute of Medicine and Dentistry
Niigata University, Niigata, Japan)
R.S. King (University of Rhode Island, Kingston,
RI, USA)
K. Knights (Flinders University, Bedford
Park, Australia)
W.A. Korfmacher (Schering-Plough Research
Institute, Kenilworth, NJ, USA)
J. Kirchheiner (University of Ulm, Ulm, Germany)
R.H. Levy (University of Washington, Seattle,
WA, USA)
A.P. Li (Advanced Pharmaceutical Sciences
Inc, Rockville, MD, USA)
J. Lin (Merck Research Laboratories, West
Point, PA, USA)
S. Lossdörfer (University of Bonn, Bonn,
Germany)
P.I. Mackenzie (Flinders Medical Centre,
Bedford Park, Australia)
A.E. Mutlib (Wyeth Research, Collegeville,
PA, USA)
A.F. Nassar (Vion Pharmaceuticals Inc., Milford,
CT, USA)
K.B. Park (University of Liverpool, Liverpool,
UK)
T. Prueksaritanont (Merck Research Laboratories,
West Point, PA, USA)
A.D. Rodrigues (Bristol-Myers Squibb, Princeton,
NJ, USA)
A. Rostami-Hodjegan (University of Sheffield,
Sheffield, UK)
T. Rushmore (Merck Research Laboratories,
West Point, PA, USA)
J.F. Rusling (University of Connecticut,
Storrs, CT, USA)
J. Sahi (CellzDirect Inc., Ann Arbor MI,
USA)
M. Sinz (Bristol-Myers Squibb, Wallingford,
CT, USA)
S.R. Tannenbaum (Massachusetts Institute
of Technology, Cambridge, MA, USA)
B.L Tekwani (University of Mississippi, University
MS, USA)
J. Uetrecht (University of Toronto, Toronto
Ontario, Canada)
R.E. White (Schering-Plough Research Institute,
Kenilworth, NJ, USA)
W. Xie (University of Pittsburgh School of
Pharmacy, Pittsburgh, PA, USA)
H. Yamazaki (Hokkaido Univ. Graduate Sch.
Pharm. Sci., Hokkaido, Japan)
Reviewer Panel:
José A.G. Agúndez
(University of Extremadura, Badajoz, Spain)
Pavel Anzenbacher (Palacky University, Olomouc,
Czech Republic)
Dean Brian (Array Biopharma, Boulder, CO,
USA)
Eli Chan (National University of Singapore,
Republic of Singapore)
Kuo-Chi Cheng (Schering-Plough Research Institute,
Kenilworth, NJ, USA)
Mano Chetty (Faculty of Pharmacy, University
of Sydney, Sydney, Australia)
Balram Chowbay (National Cancer Centre, Singapore)
Carol Collins (University of Washington,
Seattle, WA, USA)
M. Teresa Donato (Universitat de València,
Valencia, Spain)
Zdenek Dvorak (Palacky University Olomouc,
Czech Republic)
Dietmar Fuchs (Innsbruck Medical University,
Innsbruck, Austria)
Lawrence L. Gan (Biogen Idec., Inc., Cambridge,
MA, USA)
Ken Grime (AstraZeneca Research and Development,
Loughborough, UK )
Jingkai Gu (Jilin University, Changchun,
China)
Nuala Helsby (University of Auckland, Auckland,
New Zealand)
Nicky Hewitt (Scientific Writing Services,
Erzhausen, Germany)
Paavo Honkakoski (University of Kuopio, Kuopio,
Finland)
Ming Hu (University of Houston, Houston,
TX, USA)
Brian Houston (University of Manchester,
Manchester , UK)
Federico Innocenti (University of Chicago,
Chicago IL, USA)
Youssef Jounaidi (Boston University, Boston,
MA, USA)
Ayman El-Kadi (University of Alberta, Edmonton,
Canada)
Amit S. Kalgutkar ( Pfizer Global Research
and Development, Groton, CT, USA)
Raymond A. Kemper (Boehringer Ingelheim Pharmaceuticals
Inc., Ridgefield, CT, USA)
Gordon M. Kirby (University of Guelph, Guelph,
Ontario, Canada)
Joshua Lambert (The Pennsylvania State University,
University Park, PA, USA)
Ming-Cheh Liu (University of Toledo, Toledo
OH, USA )
Punit H. Marathe (Bristol-Myers Squibb, Princeton,
NJ, USA)
Fátima Martel (University of Porto,
Porto, Portugal)
H.C. Hans H. Maurer (Saarland University,
Hamburg, Germany)
Andrew McLachlan (Univ. of Sydney and Concord
Hospital, Sydney, Australia)
Ralf P. Meyer (University of Freiburg Freiburg,
Germany)
Akiyoshi Nishikawa (National Institute of
Health Sciences, Tokyo, Japan)
Andras Palotas (sklepios-Med Bt, Szeged,
Hungary)
Erin Schuetz (St Jude Children's Research
Hospital, Memphis, TN, USA)
Mohammad-Reza Shiran (University of Medical
Sciences, Sari, Iran)
Wei Tang (Merck Research Laboratories, Rahway,
NJ, USA)
Yune-Fang Ueng (Nat. Res. Inst.of Chinese
Med., Taipei, Taiwan)
Karthik Venkatakrishnan (Millennium Pharmaceuticals
Inc., Cambridge, MA, USA)
Brad Wong (Amgen, South San Francisco, CA,
USA)
Zhengyin Yan (Johnson & Johnson Pharmaceutical
Research & Development, Spring House, PA, USA)
Aiming Yu (University of New York, Buffalo,
NY, USA)
Chul-Ho Yun (Chonnam National University,
Gwangju, Republic of Korea)
Ji Yue Zhang (GlaxoSmithKline R&D, Shanghai,
China) |